• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Biochemical liver profile in hemochromatosis. A survey of 100 patients.

作者信息

Lin E, Adams P C

机构信息

Department of Medicine, University Hospital, University of Western Ontario, London, Canada.

出版信息

J Clin Gastroenterol. 1991 Jun;13(3):316-20. doi: 10.1097/00004836-199106000-00013.

DOI:10.1097/00004836-199106000-00013
PMID:2066547
Abstract

To determine the frequency of liver profile abnormalities in hereditary hemochromatosis, we under took a retrospective survey in 100 patients, all of whom had undergone liver biopsy. Liver histology was compared with the biochemical profile, which included aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, bilirubin and albumin determinations. Mild abnormalities in the AST and ALT levels were seen in more than 65% of patients. Patients with cirrhosis had significantly greater elevations in AST, ALT, and alkaline phosphatase, and a significant decrease in albumin (p less than 0.05). Proband cases had more frequent abnormalities than discovered cases within families. Accordingly, we find that mild abnormalities in the biochemical liver profile are common in hemochromatosis and suggest that patients with an unexplained abnormality in the liver profile should be screened for hemochromatosis with a serum ferritin and transferrin saturation.

摘要

相似文献

1
Biochemical liver profile in hemochromatosis. A survey of 100 patients.
J Clin Gastroenterol. 1991 Jun;13(3):316-20. doi: 10.1097/00004836-199106000-00013.
2
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.美国胃肠病学会临床指南:异常肝功能检查结果的评估
Am J Gastroenterol. 2017 Jan;112(1):18-35. doi: 10.1038/ajg.2016.517. Epub 2016 Dec 20.
3
Hepatic iron clearance from serum in treated hemochromatosis.治疗性血色素沉着症中血清铁的肝脏清除率。
Gastroenterology. 1978 Nov;75(5):856-9.
4
Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.对转氨酶水平正常的C282Y纯合子血色素沉着症患者隐匿性肝纤维化的评估。
Clin Gastroenterol Hepatol. 2008 Jun;6(6):713-4. doi: 10.1016/j.cgh.2008.02.024.
5
Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis.血清铁蛋白水平可预测美国表型血色素沉着症患者的晚期肝纤维化。
Ann Intern Med. 2003 Apr 15;138(8):627-33. doi: 10.7326/0003-4819-138-8-200304150-00008.
6
Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients.稳态镰状细胞贫血患者中肝功能生化检测与年龄的关系评估
Niger J Clin Pract. 2017 Nov;20(11):1428-1433. doi: 10.4103/njcp.njcp_14_17.
7
Biochemical changes in patients with combined chronic schistosomiasis and viral hepatitis C infections.合并慢性血吸虫病和丙型病毒性肝炎感染患者的生化变化
Dis Markers. 2000;16(3-4):111-8. doi: 10.1155/2000/732754.
8
Hereditary Hemochromatosis.遗传性血色素沉着症
J Coll Physicians Surg Pak. 2015 Sep;25(9):644-7.
9
Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.肝细胞癌和肝硬化:钇-90树脂微球放射性栓塞术后或CT引导下高剂量率近距离放射治疗后的肝功能评估
Dig Dis. 2009;27(2):189-99. doi: 10.1159/000218352. Epub 2009 Jun 22.
10
Severe Elevation of Liver Tests in Choledocholithiasis: An Uncommon Occurrence With Important Clinical Implications.胆总管结石患者肝功能检查严重升高:一种罕见情况,具有重要临床意义。
J Clin Gastroenterol. 2017 Sep;51(8):728-733. doi: 10.1097/MCG.0000000000000608.

引用本文的文献

1
The Genetic Diagnostics of Hemochromatosis: Disparities in Low- Versus High-Income Countries.血色素沉着症的基因诊断:低收入国家与高收入国家的差异
Cureus. 2024 Jul 8;16(7):e64074. doi: 10.7759/cureus.64074. eCollection 2024 Jul.
2
Copper, Iron, Cadmium, and Arsenic, All Generated in the Universe: Elucidating Their Environmental Impact Risk on Human Health Including Clinical Liver Injury.铜、铁、镉、砷,宇宙中全部生成:阐明其对人类健康包括临床肝损伤的环境影响风险。
Int J Mol Sci. 2024 Jun 17;25(12):6662. doi: 10.3390/ijms25126662.
3
Abnormal liver enzymes: A review for clinicians.
肝功能异常酶:临床医生综述
World J Hepatol. 2021 Nov 27;13(11):1688-1698. doi: 10.4254/wjh.v13.i11.1688.
4
An efficient machine learning-based approach for screening individuals at risk of hereditary haemochromatosis.一种基于机器学习的高效方法,用于筛选遗传性血色素沉着症风险个体。
Sci Rep. 2020 Nov 26;10(1):20613. doi: 10.1038/s41598-020-77367-6.
5
Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.血色病中的肝硬化:368 名 HFE p.C282Y 纯合子的独立危险因素。
Ann Hepatol. 2018 Aug 24;17(5):871-879. doi: 10.5604/01.3001.0012.3169.
6
GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes.GNPAT基因p.D519G突变与HFE基因p.C282Y纯合子中铁储存显著增加独立相关。
Blood Cells Mol Dis. 2017 Mar;63:15-20. doi: 10.1016/j.bcmd.2016.11.009. Epub 2016 Nov 12.
7
Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.在铁负荷过多症和血色病筛查研究中,高血铁蛋白血症患者的肝转氨酶活性升高,C282Y 纯合子的可能性降低。
Hepatology. 2012 Jun;55(6):1722-6. doi: 10.1002/hep.25538. Epub 2012 Apr 18.
8
The myths and realities of hemochromatosis.血色素沉着症的 myths 与真相。 (注:这里“myths”直译为“神话、虚构之事”,结合语境可灵活意译为更合适表述)
Can J Gastroenterol. 2007 Feb;21(2):101-4. doi: 10.1155/2007/619401.
9
The diversity of liver diseases among outpatient referrals for an elevated serum ferritin.血清铁蛋白升高的门诊转诊患者中肝脏疾病的多样性。
Can J Gastroenterol. 2006 Jul;20(7):467-70. doi: 10.1155/2006/357340.
10
Individuals homozygous for the H63D mutation have significantly elevated iron indexes.携带H63D突变的纯合个体铁指标显著升高。
Dig Dis Sci. 2006 Apr;51(4):803-7. doi: 10.1007/s10620-006-3210-3.